Nathoe Hendrik M, Buskens Erik, Jansen Erik W L, Suyker Willem J L, Stella Pieter R, Lahpor Jaap R, van Boven Wim-Jan, van Dijk Diederik, Diephuis Jan C, Borst Cornelius, Moons Karel G M, Grobbee Diederick E, de Jaegere Peter P T
Department of Cardiology, Heart Lung Center Utrecht, Utrecht, The Netherlands.
Circulation. 2004 Sep 28;110(13):1738-42. doi: 10.1161/01.CIR.0000143105.42988.FD. Epub 2004 Sep 20.
Collaterals limit infarct size, preserve viability, and reduce mortality in patients with acute myocardial infarction. In patients with stable coronary disease, collaterals are associated with less angina and ischemia during angioplasty and fewer ischemic events during follow-up. The role of collaterals has not been studied in patients undergoing off-pump or on-pump bypass surgery.
The population consisted of the 281 patients randomized to off-pump or on-pump CABG in the Octopus Study. Collaterals were defined on the baseline angiogram with the Rentrop score and were present in 49% and 51% of the patients in the off-pump and on-pump group, respectively. Perioperative myocardial infarction was defined by a creatine kinase-MB to CK ratio >10% and occurred in 18.2% in the off-pump group and 32.5% in the on-pump group. The unadjusted OR of perioperative myocardial infarction in the presence of collaterals was 0.31 (95% CI 0.17 to 0.84) in the off-pump group and 1.06 (95% CI 0.29 to 3.85) in the on-pump group After adjustment for age, gender, hypertension, hypercholesterolemia, diabetes, multivessel disease, ventricular dysfunction, incomplete revascularization, and ischemic time, the OR was 0.34 (95% CI 0.14 to 0.84) in the off-pump group and 1.28 (95% CI 0.30 to 5.40) in the on-pump group, respectively. Kaplan-Meier estimates of event-free survival at 1 year were 87% in patients with and 69% in those without collaterals after off-pump CABG. These estimates were 66% and 63%, respectively, after on-pump CABG.
Collaterals protect against perioperative myocardial infarction during off-pump surgery but not during on-pump surgery and are associated with a better 1-year event-free survival.
在急性心肌梗死患者中,侧支循环可限制梗死面积、维持心肌活力并降低死亡率。在稳定型冠心病患者中,侧支循环与血管成形术期间心绞痛和缺血症状减轻以及随访期间缺血事件减少相关。尚未对接受非体外循环或体外循环搭桥手术的患者中侧支循环的作用进行研究。
研究人群包括章鱼研究中随机接受非体外循环或体外循环冠状动脉旁路移植术(CABG)的281例患者。根据Rentrop评分在基线血管造影上定义侧支循环,非体外循环组和体外循环组中分别有49%和51%的患者存在侧支循环。围手术期心肌梗死定义为肌酸激酶同工酶(CK-MB)与总肌酸激酶(CK)之比>10%,非体外循环组发生率为18.2%,体外循环组为32.5%。非体外循环组中存在侧支循环时围手术期心肌梗死的未调整比值比(OR)为0.31(95%可信区间[CI]0.17至0.84),体外循环组为1.06(95%CI0.29至3.85)。在对年龄、性别、高血压、高胆固醇血症、糖尿病、多支血管病变、心室功能障碍、血管再通不完全和缺血时间进行调整后,非体外循环组的OR为0.34(95%CI0.14至0.84),体外循环组为1.28(95%CI0.30至5.40)。非体外循环CABG术后,有侧支循环患者1年无事件生存率的Kaplan-Meier估计值为87%,无侧支循环患者为69%。体外循环CABG术后,这些估计值分别为66%和63%。
侧支循环在非体外循环手术期间可预防围手术期心肌梗死,但在体外循环手术期间则不能,并且与更好的1年无事件生存率相关。